The European Society for Medical Oncology (ESMO), together with Oxford Journals, and the Japanese Society of Medical Oncology (JSMO) are pleased to announce a new collaboration which will result in ESMO’s official journal Annals of Oncology becoming the official scientific publication for the Japanese society.
Annals of Oncology is fully owned by ESMO and is published by Oxford Journals. From 2008, the journal will be endorsed by JSMO and all members of the Japanese society will have online access to the journal, increasing the distribution to approximately 15,000. Annals of Oncology will take on two additional Associate Editors and 12 new Editorial Board members from Japanese institutions. To mark the beginning of this new collaboration, the first issue of 2008 will focus on Japanese authors.
"This is great news for JSMO and for the journal," commented Prof. David Kerr, Editor-in-Chief of Annals of Oncology and ESMO President-Elect 2008-2009. "Japanese groups have made significant contributions to the journal in recent years, and I am proud that JSMO has now chosen Annals as their official journal."
He continued, "The success of Annals of Oncology is based on quality of service, content, and access. These are values that have always been key to ESMO and that are also shared by JSMO. This collaboration will help us to build on the success of the journal. I truly hope that we can be an example of how, by working together, using science to inform our decisions, and considering the real needs of our populations, we can shape the future of oncology for the better."
Dr Nagahiro Saijo, President of JSMO, added, “We are delighted to have Annals of Oncology as JSMO’s official journal, and that all our members will have access to its top quality research. Through this partnership we hope to strengthen the ties between Japanese and European researchers and to increase the number of Japanese papers published in the journal. We believe that the JSMO Associate Editors and Editorial Board members will help to encourage the exchange of opinions and research within the global oncology community.”
Annals of Oncology is a global leader among clinical oncology journals and saw an increase in its impact factor from 4.319 to 5.179 in the latest Journal Citation Reports. For further information on the journal please see http://annonc.oxfordjournals.org/.
For further info please contact:
For ESMO
Vanessa Pavinato
Communication Coordinator
European Society for Medical Oncology
media@esmo.org
+41 (0)91 973 19 07
For JSMO
Dr. T. Naoe
Press contact
Japanese Society of Medical Oncology
tnaoe@med.nagoya-u.ac
For Oxford Journals
Kate Stringer
Assistant Communications Manager
Oxford Journals
kate.stringer@oxfordjournals.org
+44 (0)1865 354585
Additional information can also be obtained at the ESMO and OUP booths during ECCO 14.
Notes for Editors
The European Society for Medical Oncology (ESMO) is the leading European non-profit, professional organization for medical oncology promoting multidisciplinary cancer treatment around the world. ESMO unites medical oncologists and other oncology specialists, healthcare professionals, caregivers, patients, policy-makers, the media and other key stakeholders in a global alliance committed to eradicating cancer and ensuring equal access to high quality treatment for all patients. Thanks to its state-of-the-art education and training programs, ESMO plays an instrumental role in providing the oncology community with the most up-to-date scientific research and information available. Annals of Oncology, ESMO’s flagship journal, ranks among the top five clinical oncology journals worldwide. ESMO is dedicated to educating and supporting oncologists, optimizing patient care, disseminating cancer-specific information to the public, and advocating patient rights. As an authoritative voice in the fight against cancer, ESMO provides both the platform and the consultative expertise to influence national and international organizations, as well as European authorities, in order to establish common standards for a multidisciplinary approach to cancer treatment.
The Japanese Society of Medical Oncology (JSMO) is the leading Japanese professional organization representing medical oncologists in Japan. JSMO is dedicated to improving the health and welfare of cancer patients through research, education, and the practice of cancer medicine. The organization aims to promote interest in medical oncology through its activities which include hosting academic meetings and educational seminars, and publishing textbooks. There are 11 committees associated with JSMO, with more than 100 volunteers. The organization currently has approximately 6,300 members. From 2008 onwards Annals of Oncology will be the official scientific publication of JSMO.
Oxford University Press (OUP), a department of the University of Oxford, is the world's largest and most international university press. Founded in 1478, it currently publishes more than 4,500 new books a year, has a presence in over 50 countries, and employs some 3,700 people worldwide. It has become familiar to millions through a diverse publishing program that includes scholarly works in all academic disciplines, bibles, music, school and college textbooks, children's books, materials for teaching English as a foreign language, business books, dictionaries and reference books, and journals.
Oxford Journals, a Division of OUP, publishes nearly 200 journals covering a broad range of subject areas, two-thirds of which are published in collaboration with learned societies and other international organizations. The collection contains some of the world's most prestigious titles, including Nucleic Acids Research, JNCI (Journal of the National Cancer Institute), Brain, Human Reproduction, English Historical Review, and the Review of Financial Studies.